Neoadjuvant Therapy with Weekly Nanoparticle Albumin‐Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011‐02), a Multicenter, Non‐Randomized, Phase II Trial, with a Companion Biomarker Analysis

BACKGROUND. Nanoparticle albumin‐bound paclitaxel (nab‐Paclitaxel) is an alternative to standard taxanes for breast cancer (BC) treatment. We evaluated nab‐Paclitaxel efficacy as neoadjuvant treatment for early estrogen receptor‐positive (ER+), human epidermal growth factor receptor 2‐negative (HER2...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Main Authors: Martín, Miguel, Chacón, José I., Antón, Antonio, Plazaola, Arrate, García‐Martínez, Elena, Seguí, Miguel A., Sánchez‐Rovira, Pedro, Palacios, José, Calvo, Lourdes, Esteban, Carmen, Espinosa, Enrique, Barnadas, Agusti, Batista, Norberto, Guerrero, Angel, Muñoz, Montserrat, Romio, Estefania, Rodríguez‐Martín, César, Caballero, Rosalía, Casas, María I., Rojo, Federico, Carrasco, Eva, Antolín, Silvia
Formato: Artigo
Idioma:Inglês
Publicado: AlphaMed Press 2017
Assuntos:
Breast Cancer
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5679821/
https://ncbi.nlm.nih.gov/pubmed/28701571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0052
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares